Related Experiment Video
Updated: Aug 18, 2026

Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administration
G Coppi1, V Iannuccelli, N Sala
1Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Via Campi, 183, 41100 Modena, Italy. coppi.gilberto@unimore.it
Abstract:
Microparticles with size less than 3 microm, able to be taken up by M cell of Peyer's patches for the drug delivery to the Gut Associated Limphoid Tissue (GALT), were developed in order to improve oral bioavailability of Polymyxin B (PMB). Less than 3 microm alginate microparticles resistant to gastro-intestinal media were prepared by spray-drying technique and cross-linking by calcium ions and chitosan. The cross-linked microparticles were evaluated for PMB content by spectrophotometric method, alginate/PMB interaction by rheological study, cross-linking degree by EDS analysis and PMB activity by microbiological assay. By modulating the polymer cross-linking degree, cationic PMB interacted on alginate chains leading to a proper PMB loading as well as antibiotic retention in gastric environment and sustained delivery in intestinal fluid. Moreover, the procedure resulted suitable for PMB biological activity preservation.
Insights
Novel microparticles enhance oral drug delivery by protecting Polymyxin B (PMB) in the gastrointestinal tract. This approach improves drug bioavailability for targeted delivery to the Gut Associated Limphoid Tissue (GALT).
Area of Science:
- Pharmaceutics and Drug Delivery
- Biomaterials Science
- Microbiology
Background:
- Oral administration of drugs like Polymyxin B (PMB) is often limited by poor bioavailability.
- The Gut Associated Limphoid Tissue (GALT) is a key target for localized drug delivery within the intestine.
- M cells in Peyer's patches offer a pathway for targeted uptake into the GALT.
Purpose of the Study:
- To develop microparticles for improved oral delivery of Polymyxin B (PMB).
- To enhance PMB's oral bioavailability by protecting it within the gastrointestinal tract.
- To facilitate drug delivery to the Gut Associated Limphoid Tissue (GALT) via M cell uptake.
Main Methods:
- Preparation of sub-3-micrometer alginate microparticles using spray-drying.
- Cross-linking of microparticles with calcium ions and chitosan to ensure gastrointestinal resistance.
- Evaluation of PMB loading, alginate/PMB interaction, cross-linking degree, and PMB activity using spectrophotometry, rheology, EDS, and microbiological assays.
Main Results:
- Optimized cross-linking of alginate microparticles enabled effective loading and retention of cationic PMB in gastric conditions.
- Sustained release of PMB was achieved in intestinal fluid.
- The developed microparticle system preserved the biological activity of Polymyxin B.
Conclusions:
- Sub-3-micrometer alginate-chitosan microparticles are a promising system for oral delivery of Polymyxin B.
- This formulation enhances PMB's oral bioavailability and enables targeted delivery to the GALT.
- The method ensures the preservation of the antibiotic's therapeutic efficacy.
More Related Videos
08:26Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices
Published on: January 30, 2026
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Production of Antibiotics